Maravai LifeSciences (MRVI) shareholders approve directors, auditor and pay at 2026 meeting
Rhea-AI Filing Summary
Maravai LifeSciences Holdings, Inc. reported the results of its 2026 Annual Meeting of Shareholders. As of the March 27, 2026 record date, the company had 258,180,170 shares of common stock outstanding, including 147,496,090 Class A shares and 110,684,080 Class B shares.
Shareholders holding 236,082,968 shares were present in person or by proxy, establishing a quorum. Three directors — Bernd Brust, Gregory T. Lucier and Luke Marker — were elected to three-year terms ending at the 2029 Annual Meeting. Shareholders also ratified Deloitte & Touche LLP as independent registered public accounting firm for the year ending December 31, 2026, and approved on a non-binding advisory basis the compensation of the named executive officers.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Total shares outstanding: 258,180,170 shares
Class A shares outstanding: 147,496,090 shares
Class B shares outstanding: 110,684,080 shares
+5 more
8 metrics
Total shares outstanding
258,180,170 shares
Common stock outstanding as of March 27, 2026 record date
Class A shares outstanding
147,496,090 shares
Class A common stock as of March 27, 2026
Class B shares outstanding
110,684,080 shares
Class B common stock as of March 27, 2026
Shares represented at meeting
236,082,968 shares
Shares of common stock present in person or by proxy
Auditor ratification votes for
234,492,897 votes
Votes for Deloitte & Touche LLP for year ending December 31, 2026
Auditor ratification votes against
1,246,939 votes
Votes against Deloitte & Touche LLP
Say-on-pay votes for
200,054,156.49 votes
Advisory approval of named executive officer compensation
Say-on-pay broker non-votes
33,258,969.51 votes
Broker non-votes on executive compensation proposal
Key Terms
Annual Meeting of Shareholders, record date, independent registered public accounting firm, broker non-votes, +1 more
5 terms
record date financial
"On March 27, 2026, the record date for the Annual Meeting, the Company had an aggregate of 258,180,170 shares"
The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.
independent registered public accounting firm financial
"Proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
broker non-votes financial
"Votes For, Votes Against, Abstentions, Broker Non-Votes 200,054,156.49 | 2,457,403.00 | 312,439.00 | 33,258,969.51"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
non-binding advisory basis financial
"Proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers"
A non-binding advisory basis is guidance or a recommendation offered for informational purposes that does not create legal obligations or guarantees; recipients can accept, modify, or ignore it without contractual consequences. Investors should treat it like a weather forecast for planning—useful for forming expectations and assessing risk, but not a firm promise—so they should verify assumptions, seek confirming information, and avoid relying on it as the sole basis for investment decisions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
Was there a quorum at Maravai LifeSciences’ 2026 Annual Meeting?
Yes. Holders of 236,082,968 shares of common stock were present in person or by proxy at the 2026 Annual Meeting, which constituted a quorum and allowed the company to conduct official shareholder business and vote on the three proposals.
Which directors were elected at Maravai LifeSciences’ 2026 Annual Meeting?
Shareholders elected Bernd Brust, Gregory T. Lucier and Luke Marker as directors. Each will serve a three-year term expiring at the 2029 Annual Meeting of Shareholders and continue until a successor is elected and qualified or earlier death, resignation or removal.